drugset / Trial / NCT06354257
A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age
Non-randomizedSequentialOpen-labelPrevention
Summary
The purpose of this study is to provide data showing if there are any effects of GSK3036656 on a combined oral contraceptive containing Ethinyl Estradiol (EE) and Levonorgestrel (LNG), which will help inform future studies on suitable contraceptive measures to be used.
Timeline
- Start
- 2024-04-05
- Primary completion
- 2024-07-01
- Completion
- 2024-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ganfeborole | Small molecule | 20 mg | — |
| Subject | Microgynon | Unknown | 0.03 mg | Oral |
| Subject | Microgynon | Unknown | 0.15 mg | Oral |